ORKA

Oruka Therapeutics, Inc. Common Stock
ORKA
Market cap $1.01B

28.81 USD

-0.20

0.69%

At close Oct 17, 4:00 PM EDT

1 day

-0.69%

5 days

7.10%

1 month

8.84%

3 months

2.93%

6 months

2.93%

Year to date

2.93%

1 year

2.93%

5 years

2.93%

About: Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Healthcare In Vitro & In Vivo Diagnostic Substances

–

Funds holding %

of 6,740 funds

Analysts bullish %

of 7 analysts

Fund manager confidence

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$40

39%

upside

Avg. target

$43

50%

upside

High target

$49

70%

upside

7 analyst ratings

7 positive

100%

0 neutral

0 negative

Stifel Alex Thompson 60% 1-year accuracy 6 / 10 met price target	70%upside $49	Buy Initiated	11 Oct 2024
HC Wainwright & Co. Mitchell Kapoor 49% 1-year accuracy 64 / 131 met price target	56%upside $45	Buy Initiated	7 Oct 2024
Leerink Partners David Risinger 100% 1-year accuracy 3 / 3 met price target	53%upside $44	Outperform Initiated	17 Sept 2024
Leerink Swann David Risinger 100% 1-year accuracy 3 / 3 met price target	53%upside $44	Outperform Initiated	17 Sept 2024
LifeSci Capital	42%upside $41	Outperform Initiated	16 Sept 2024